A recent study shows that mitochondrial networks in the two main subtypes of non-small cell lung cancer, adenocarcinoma and squamous cell carcinoma, are structurally and functionally distinct. This difference could impact therapeutic targeting of cancer metabolism, a complex field that has been slow to bear fruit.